satavaptan has been researched along with Cirrhoses, Experimental Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arroyo, V; Cano, C; Cejudo, P; Gal, CS; Jiménez, W; Maffrand, JP; Morales-Ruiz, M; Pascal, M; Rivera, F; Rodés, J; Ros, J | 1 |
| Jiménez, W | 1 |
1 review(s) available for satavaptan and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
[Aquaretic agents].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Aquaporin 6; Aquaporins; Ascites; Benzeneacetamides; Body Water; Demeclocycline; Diuresis; Diuretics; Humans; Kidney Tubules, Collecting; Liver Cirrhosis; Liver Cirrhosis, Experimental; Morpholines; Pyrrolidines; Rats; Receptors, Opioid, kappa; Receptors, Vasopressin; Spiro Compounds; Vasopressins | 2002 |
1 other study(ies) available for satavaptan and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Body Water; Liver Cirrhosis, Experimental; Male; Morpholines; Rats; Rats, Wistar; Sodium; Spiro Compounds | 2000 |